Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (5)

2021

  1. Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: Proof-of-concept study

    BMJ Open, Vol. 11, Núm. 10

2019

  1. Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

    American Journal of Transplantation, Vol. 19, Núm. 11, pp. 3018-3034

2018

  1. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

    Journal of the American Society of Nephrology, Vol. 29, Núm. 7, pp. 1979-1991

2016

  1. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients

    Nephrology Dialysis Transplantation, Vol. 31, Núm. 6, pp. 1002-1013

2013

  1. TRANSFORM: A novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation

    Open Access Journal of Clinical Trials, Vol. 6, pp. 45-53